A. Byatte

The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity

S. Halford, K. Chester, R. Guest, 2017, Cancer Immunology, Immunotherapy.